Drug
Iov 2001
Iov 2001: highest development phase Phase 1, developed by Iovance Biotherapeutics. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Iovance Biotherapeutics
Trials
| Drug | Phase | Indication |
|---|---|---|
| IOV-2001 NCT04155710 | Phase 1 | Chronic Lymphocytic Leukemia |
Latest
No recent events.
Follow Iov 2001 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.